Table 2.
Oral carriage of respiratory pathogens from participants with RTI symptoms (RTI-S) and those who remained healthy (no-RTI) at three time points (TP).
| Carriage prevalence percent (%) |
|||||
|---|---|---|---|---|---|
| Respiratory pathogen | RTI-S |
No-RTI |
|||
| TP-A (n = 19) | TP-B (n = 19) | TP-C (n = 17) | TP-A (n = 21) | TP-C (n = 21) | |
| CoNS | 73.7* | 84.2 | 76.5 | 42.8* | 47.6 |
| S. aureus | 0 | 5.3 | 5.9 | 14.2 | 9.5 |
| F. necrophorum | 5.3 | 5.3 | 0.00 | 4.8 | 4.8 |
| H. influenzae | 26.3 | 31.6 | 29.4 | 19.0 | 14.2 |
| M. pneumoniae | 5.3 | 5.3 | 0.0 | 9.5 | 0.0 |
| S. pneumoniae | 26.3 | 10.5 | 23.5 | 23.8 | 9.5 |
| M. catarrhalis | 10.5 | 5.3 | 17.6 | 14.2 | 9.5 |
| Parechovirus | 0 | 5.3 | 0.00 | 0 | 0 |
| Rhinovirus | 0 | 5.3 | 5.9 | 0 | 0 |
| Rhinovirus-2 | 5.3 | 5.3 | 5.9 | 0 | 0 |
| Influenza A | 0 | 15.7 | 11.8 | 4.7 | 9.5 |
*Bonferroni-adjusted, p = 0.0045 (Pearson’s chi-squared, p = 0.049). All RTI-S and no-RTI saliva and RTI-S stool samples tested negative for human coronavirus Beta-Cov, E gene and SARS-CoV-2, S gene. Abbreviations: Coagulase-negative staphylococci (CoNS), time point (TP): A, baseline; B, RTI symptoms; C, end of study/RTI-recovery.